Trivium Point Advisory LLC Makes New Investment in Cencora, Inc. $COR

Trivium Point Advisory LLC acquired a new stake in shares of Cencora, Inc. (NYSE:COR) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 1,806 shares of the company’s stock, valued at approximately $511,000.

Several other institutional investors and hedge funds also recently made changes to their positions in COR. Kemnay Advisory Services Inc. acquired a new stake in shares of Cencora during the 4th quarter worth about $25,000. Oakworth Capital Inc. bought a new position in Cencora during the 4th quarter valued at about $26,000. Elyxium Wealth LLC acquired a new position in Cencora in the fourth quarter valued at about $27,000. Elevation Wealth Partners LLC boosted its position in Cencora by 506.2% in the second quarter. Elevation Wealth Partners LLC now owns 97 shares of the company’s stock valued at $27,000 after buying an additional 81 shares in the last quarter. Finally, Archer Investment Corp boosted its position in Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after buying an additional 47 shares in the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on COR. Barclays dropped their price objective on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, June 10th. JPMorgan Chase & Co. boosted their target price on Cencora from $382.00 to $390.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. William Blair assumed coverage on Cencora in a research report on Tuesday, April 28th. They set a “market perform” rating on the stock. Morgan Stanley raised their price target on Cencora from $342.00 to $346.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Finally, Wall Street Zen upgraded Cencora from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Thirteen investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cencora presently has an average rating of “Moderate Buy” and a consensus price target of $374.25.

Insider Transactions at Cencora

In other news, Director Lauren M. Tyler acquired 550 shares of Cencora stock in a transaction on Monday, June 22nd. The shares were purchased at an average price of $270.23 per share, with a total value of $148,626.50. Following the acquisition, the director owned 4,359 shares in the company, valued at $1,177,932.57. This represents a 14.44% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.38% of the company’s stock.

Cencora Trading Up 0.0%

COR opened at $313.86 on Monday. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54. The stock has a market capitalization of $59.89 billion, a PE ratio of 23.32, a PEG ratio of 1.80 and a beta of 0.57. The company has a current ratio of 0.93, a quick ratio of 0.58 and a debt-to-equity ratio of 3.53. The firm has a 50-day moving average price of $298.98 and a two-hundred day moving average price of $312.94.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, August 5th. The company reported $4.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.35 by $0.13. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The company had revenue of $84.75 billion for the quarter, compared to analyst estimates of $84.31 billion. During the same period in the prior year, the business earned $4.00 earnings per share. Cencora’s quarterly revenue was up 5.1% on a year-over-year basis. As a group, equities analysts anticipate that Cencora, Inc. will post 17.84 earnings per share for the current fiscal year.

Cencora Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be given a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.8%. The ex-dividend date is Friday, August 14th. Cencora’s payout ratio is 17.83%.

Cencora announced that its board has authorized a share repurchase program on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to reacquire up to 3.9% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.